Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,396 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A double-blind, placebo-controlled trial of reserpine for the treatment of cocaine dependence.
Winhusen T, Somoza E, Sarid-Segal O, Goldsmith RJ, Harrer JM, Coleman FS, Kahn R, Osman S, Mezinskis J, Li SH, Lewis D, Afshar M, Ciraulo DA, Horn P, Montgomery MA, Elkashef A. Winhusen T, et al. Among authors: lewis d. Drug Alcohol Depend. 2007 Dec 1;91(2-3):205-12. doi: 10.1016/j.drugalcdep.2007.05.021. Epub 2007 Jul 12. Drug Alcohol Depend. 2007. PMID: 17628352 Free PMC article. Clinical Trial.
A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence.
Winhusen T, Somoza E, Ciraulo DA, Harrer JM, Goldsmith RJ, Grabowski J, Coleman FS, Mindrum G, Kahn R, Osman S, Mezinskis J, Li SH, Lewis D, Horn P, Montgomery MA, Elkashef A. Winhusen T, et al. Among authors: lewis d. Drug Alcohol Depend. 2007 Dec 1;91(2-3):141-8. doi: 10.1016/j.drugalcdep.2007.05.028. Epub 2007 Jul 16. Drug Alcohol Depend. 2007. PMID: 17629631 Clinical Trial.
The SRPHK1 outcome measure for cocaine-dependence trials combines self-report, urine benzoylecgonine levels, and the concordance between the two to determine a cocaine-use status for each study day.
Somoza E, Somoza P, Lewis D, Li SH, Winhusen T, Chiang N, Vocci F, Horn P, Elkashef A. Somoza E, et al. Among authors: lewis d. Drug Alcohol Depend. 2008 Jan 11;93(1-2):132-40. doi: 10.1016/j.drugalcdep.2007.09.007. Epub 2007 Oct 29. Drug Alcohol Depend. 2008. PMID: 18029115 Clinical Trial.
Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial.
Winhusen TM, Somoza EC, Brigham GS, Liu DS, Green CA, Covey LS, Croghan IT, Adler LA, Weiss RD, Leimberger JD, Lewis DF, Dorer EM. Winhusen TM, et al. Among authors: lewis df. J Clin Psychiatry. 2010 Dec;71(12):1680-8. doi: 10.4088/JCP.09m05089gry. Epub 2010 May 18. J Clin Psychiatry. 2010. PMID: 20492837 Free PMC article. Clinical Trial.
Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention-deficit/hyperactivity disorder.
Winhusen TM, Lewis DF, Riggs PD, Davies RD, Adler LA, Sonne S, Somoza EC. Winhusen TM, et al. Among authors: lewis df. J Child Adolesc Psychopharmacol. 2011 Oct;21(5):455-63. doi: 10.1089/cap.2011.0014. J Child Adolesc Psychopharmacol. 2011. PMID: 22040190 Free PMC article. Clinical Trial.
6,396 results